Management metrics focused on pipeline progress and expansion and net sales
First written in FY2021. 13 of 14 entries say "Restated". Latest entry: FY2026-H1.
5 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2025RestatedAnnual report
「We do not use numerical management targets such as ROA (return on assets) or ROE (return on equity). However, as management metrics, we consider progress in developing pipeline programs that will generate future revenue, pipeline expansion, and revenue to be important objectives, and are pursuing our business activities accordingly.」
The company has reaffirmed its focus on pipeline development progress, expansion, and revenue as management metrics, rather than numerical targets such as ROA and ROE. - FY2025-H1RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2024-Q2RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2024-Q1RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2023RestatedAnnual report
「We do not use numerical management targets such as ROA (return on assets) or ROE (return on equity). However, as management metrics, we consider progress in developing pipeline programs that will generate future revenue, pipeline expansion, and revenue to be important objectives, and are pursuing our business activities accordingly.」
The company has reaffirmed its management focus on pipeline progress, expansion, and revenue, rather than numerical targets such as ROA or ROE. - FY2023-Q3RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2023-Q2RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2023-Q1RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2022RestatedAnnual report
「As management metrics, we consider progress in developing pipeline programs that will generate future revenue, pipeline expansion, and revenue to be important objectives, and are pursuing our business activities accordingly.」
The company has reaffirmed its policy of using pipeline progress, expansion, and revenue as important management metrics, rather than numerical targets such as ROA or ROE. - FY2022-Q3RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose the development status of pipeline programs expected to generate future revenue as key management information. - FY2022-Q2RestatedAnnual report
「The development status of our pipeline is as follows.」
The company continues to disclose pipeline development status as key business information. - FY2022-Q1RestatedAnnual report
「We have a pipeline of 4 antibodies targeting GPC3, CDH3, and the transferrin receptor, respectively, which were initially selected from candidate antibodies obtained through seed discovery based on multifaceted evaluation. Many additional candidate antibodies are in the research and development stage.」
The company has disclosed that it currently has 4 pipeline programs expected to generate future revenue, with additional candidates in the research and development stage. - FY2021First statedAnnual report
「As management metrics, we consider progress in developing pipeline programs that will generate future revenue, pipeline expansion, and revenue to be important objectives, and are pursuing our business activities accordingly.」
The company has explained that it does not use numerical targets such as ROA or ROE, but focuses on pipeline progress, expansion, and revenue.